©The Author(s) 2016.
World J Gastroenterol. Nov 21, 2016; 22(43): 9613-9622
Published online Nov 21, 2016. doi: 10.3748/wjg.v22.i43.9613
Published online Nov 21, 2016. doi: 10.3748/wjg.v22.i43.9613
Table 3 Sustained virologic response according to fibrosis score and genotype (n = 288) n (%)
| Total patients | F ≤2 (n = 144) | F 3-4 (n = 144) | P value | |||
| SVR+ | SVR- | SVR+ | SVR- | |||
| All genotypes | 288 | 133 (46) | 11 (4) | 104 (36) | 40 (14) | 0.034 |
| Genotype 1 | 56 | 26 (46) | 3 (5) | 16 (29) | 11 (20) | 0.009 |
| Genotype 2 | 4 | 0 (0) | 0 (0) | 4 (100) | 0 (0) | |
| Genotype 3 | 145 | 60 (41) | 4 (3) | 63 (43) | 18 (12) | 0.008 |
| Genotype 6 | 83 | 47 (57) | 4 (5) | 21 (25) | 11 (13) | 0.002 |
- Citation: Hlaing NKT, Banerjee D, Mitrani R, Arker SH, Win KS, Tun NL, Thant Z, Win KM, Reddy KR. Hepatitis C virus therapy with peg-interferon and ribavirin in Myanmar: A resource-constrained country. World J Gastroenterol 2016; 22(43): 9613-9622
- URL: https://www.wjgnet.com/1007-9327/full/v22/i43/9613.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i43.9613